69 related articles for article (PubMed ID: 478656)
1. Endotoxin spillover in viral hepatitis.
Magliulo E; Dietz A; Torre D; Portelli V; Scevola D
Infection; 1979; 7(3):155-6. PubMed ID: 478656
[No Abstract] [Full Text] [Related]
2. Control of endotoxinemia in liver disease by lactulose and paromomycin.
Scevola D; Magliulo E; Trpin L; Benzi-Cipelli R; Bernardi R
Boll Ist Sieroter Milan; 1979 Jul; 58(3):242-7. PubMed ID: 518757
[TBL] [Abstract][Full Text] [Related]
3. Endotoxaemia in acute viral hepatitis.
Magliulo E; Cruciani M; Dietz A; Torre D; Armignacco O; Bernardi R; Brumana N
Hepatogastroenterology; 1981 Dec; 28(6):299-303. PubMed ID: 6807792
[No Abstract] [Full Text] [Related]
4. Endotoxin, sinusoidal cells, and liver injury.
Nolan JP; Camara DS
Prog Liver Dis; 1982; 7():361-76. PubMed ID: 7051154
[No Abstract] [Full Text] [Related]
5. Hepatic uptake of endotoxin.
Ramadori G; Meyer Zum Buschenfelde KH
Gastroenterology; 1982 Aug; 83(2):521-2. PubMed ID: 7084630
[No Abstract] [Full Text] [Related]
6. [Treatment of gut-derived endotoxemia with lactulose. An experimental study].
Hou RX
Zhonghua Wai Ke Za Zhi; 1991 Apr; 29(4):248-50, 272. PubMed ID: 1874117
[TBL] [Abstract][Full Text] [Related]
7. Uptake by liver cells of endotoxin following its intravenous injection.
Ruiter DJ; van der Meulen J; Brouwer A; Hummel MJ; Mauw BJ; van der Ploeg JC; Wisse E
Lab Invest; 1981 Jul; 45(1):38-45. PubMed ID: 7253563
[No Abstract] [Full Text] [Related]
8. [Endotoxins of Gram-negative bacteria in liver diseases].
Bréchot C; Hecht Y; Ferrier JP
Gastroenterol Clin Biol; 1980 Apr; 4(4):289-305. PubMed ID: 6765202
[No Abstract] [Full Text] [Related]
9. Endotoxin and Kupffer cells in liver disease.
Tanikawa K; Sata M
Adv Exp Med Biol; 1990; 256():481-95. PubMed ID: 2327299
[No Abstract] [Full Text] [Related]
10. Cytokine stimulation of nitric oxide formation and differential regulation in hepatocytes and nonparenchymal cells of endotoxemic rats.
Spitzer JA
Hepatology; 1994 Jan; 19(1):217-28. PubMed ID: 8276358
[TBL] [Abstract][Full Text] [Related]
11. Selective hepatic drug delivery: from basic concept to clinical practice.
Van Berkel TJ
Hepatology; 1997 Dec; 26(6):1680-1. PubMed ID: 9398016
[No Abstract] [Full Text] [Related]
12. [Experience with corticosteroid therapy of acute B type viral hepatitis].
Matkovics A; Hollós I; Darvas G
Orv Hetil; 1974 Jul; 115(28):1649-52. PubMed ID: 4841560
[No Abstract] [Full Text] [Related]
13. Endotoxin-induced activation of the nuclear transcription factor kappa B and expression of E-selectin messenger RNA in hepatocytes, Kupffer cells, and endothelial cells in vivo.
Essani NA; McGuire GM; Manning AM; Jaeschke H
J Immunol; 1996 Apr; 156(8):2956-63. PubMed ID: 8609416
[TBL] [Abstract][Full Text] [Related]
14. [Glucocorticoid metabolism in the treatment of viral hepatitis].
Rudnev GP; Sheĭkman MB; Latsinik GE
Klin Med (Mosk); 1970 Jan; 48(1):72-9. PubMed ID: 5419571
[No Abstract] [Full Text] [Related]
15. [Effectiveness of using phenobarbital in the combined therapy of viral hepatitis patients].
Bogachik LI; Andreĭchin MA; Vasil'eva NA
Vrach Delo; 1983 Nov; (11):108-10. PubMed ID: 6362196
[No Abstract] [Full Text] [Related]
16. [Viral hepatitis in children].
Anton M
Viata Med Rev Inf Prof Stiint Cadrelor Medii Sanit; 1990 Apr; 38(4):73-7. PubMed ID: 2101184
[No Abstract] [Full Text] [Related]
17. Ability of various adsorbents to bind endotoxins in vitro and to prevent orally induced endotoxemia in mice.
Ditter B; Urbaschek R; Urbaschek B
Gastroenterology; 1983 Jun; 84(6):1547-52. PubMed ID: 6341160
[TBL] [Abstract][Full Text] [Related]
18. Clearance capacity of rat liver Kupffer, Endothelial, and parenchymal cells.
Praaning-van Dalen DP; Brouwer A; Knook DL
Gastroenterology; 1981 Dec; 81(6):1036-44. PubMed ID: 7286581
[TBL] [Abstract][Full Text] [Related]
19. Effect of treatment with paromomycin on endotoxemia in patients with alcoholic liver disease--a double-blind, placebo-controlled trial.
Bode C; Schäfer C; Fukui H; Bode JC
Alcohol Clin Exp Res; 1997 Nov; 21(8):1367-73. PubMed ID: 9394106
[TBL] [Abstract][Full Text] [Related]
20. [Use of no-shpa and phenicaberan in hypertonic biliary dyskinesia in patients with viral hepatitis].
Andreĭchin MA; Kiĭko LG; Il'ina NI; Gnatovich IG
Vrach Delo; 1988 Nov; (11):100-1. PubMed ID: 3238957
[No Abstract] [Full Text] [Related]
[Next] [New Search]
